The first generic drug maker to launch after a patent expires captures up to 90% of the market - and keeps most of it for years. Here’s how the Hatch-Waxman Act creates lasting dominance.
Read MoreBy Warren Howard | 12 Comments | January 11, 2026
The first generic drug maker to launch after a patent expires captures up to 90% of the market - and keeps most of it for years. Here’s how the Hatch-Waxman Act creates lasting dominance.
Read MoreConfused between rosacea and sunburn after a day in the sun? This article breaks down their early signs, crucial differences, and what to watch for in the first 24 hours. Learn when redness is more than just sun and when it’s time to worry. Helpful tips and real-life examples make it easy to know what’s happening to your skin.
Nitrosamine contamination in generic drugs has led to over 500 recalls since 2018, with carcinogenic impurities found in blood pressure meds, diabetes drugs, and antidepressants. Learn how regulators responded, why compliance is costly, and what patients should know.
Medicare Part D in 2025 caps out-of-pocket drug costs at $2,000 annually, eliminating the donut hole. Learn how the new three-phase system works, how to pick the best plan, and what you still need to pay.
Learn how urate targets guide gout treatment with allopurinol and febuxostat. Discover why hitting serum urate levels below 6 mg/dL stops flares and dissolves crystals, and how to avoid common mistakes in treatment.
A detailed side‑by‑side look at Zyvox (linezolid) versus its main alternatives, covering uses, safety, dosing, cost and how to pick the right drug.